|
Cellular Biomechanics LaboratoryDepartment of Bioengineering - Professor Cheng Dong |
|
Main Page Projects Lab Equipment Lab Members Publications Funding |
||
Current StudiesMechanisms of Melanoma Tumor Cell
Extravasation
One of the principal requirements for
cancer metastasis (cancer
spread) is tumor cell adhesion
and motility. Metastases from a primary tumor
to secondary locations throughout the body are a major cause of cancer
related deaths. In order to metastasize, tumor cells must undergo a
series of steps. First they are shed into the blood stream (intravasation), survive while traveling through the blood vessels, and
finally migrate again out of the vessels (extravasation)
into a new location in the body. Finally they must
proliferate.
Computational Fluid Dynamic (CFD) Modeling of Leukocyte Previous work done in our lab has demonstrated that PMNs can facilitate tumor cell adhesion to the endothelium. Parallel plate flow chamber experiments have shown that under different flow conditions, melanoma cells and PMNs adhere to each other and to the endothelium with different efficiencies. These results have suggested a two-step adhesion mechanism in which first PMNs adhere to the endothelium, after which tumor cells adhere to those PMNs. The primary focus of this work is the development of a computational fluid dynamics, or CFD, model to explore what affect the fluid dynamics of the system have on the interactions between PMNs and melanoma cells in a shear flow. Return to Top
MMP Studies This study aims to discover the mechanisms of tumor-endothelial interactions that aid the melanoma cell in metastasis. Matrix Metalloproteinase (MMPs), in particular, have been implicated in cancer angiogenesis, invasion, migration and metastasis. In this study, we focus on the gelatinases (MMP2, 9) and collagenase (MMP1). Endothelial cells were co-cultured with melanoma cells in a 1:1 cell ratio over 24 hours. The supernatant was collected and probed for MMP activity using both zymographies and Western Blots. Upon detection of upregulation in the secretion of a particular MMP, experiments were designed to identify the cytokine that caused this upregulation. To study the role that MMPs play in melanoma metastasis, melanoma invasion was studied using a novel in-vitro chemotaxis invasion chamber. Endothelial cells were grown on a layer of Matrigel that was coated on a filter in an invasion assay to simulate the in vivo tumor extravasation and invasion process through the blood vessel wall. Pharmacological inhibitors, neutralizing antibodies, and/or siRNA knockouts from melanoma cells were applied, respectively, to examine effects of inflammatory cytokine-mediated MMP on melanoma invasion through the endothelium and extracellular matrix Human umbilical endothelial cells (HUVEC) and 3 highly metastatic human melanoma cell lines (Lu1205, A2058 and WM9) were co-cultured for 24 hours. It was found that MMP-2 was upregulated and secreted into the supernatant from the co-cultures of all 3 melanoma cell lines, with the highest expression using Lu1205. Blocking IL-8 in the co-culture resulted in reduced expression of MMP2, confirming that IL-8 is the target cytokine. The secretion of tissue inhibitor of MMP 2 (TIMP2) is also found to be upregulated from the melanoma-HUVEC co-culture. From literature, we suspect the source of the MMP2 and TIMP2 is primarily from the endothelials cells, however, we intend to confirm this. Invasion assays using endothelial cells grown on Matrigel are currently being investigated. There is strong evidence to suggest that IL-8 is responsible for increased expression of MMP2 into the supernatant. MMP2, a gelatinase, has been implicated in both metastasis and angiogenesis in cancer and this allows us to understand more of the tumor microenvironment in order to effectively apply therapy.
Tumor Cell Induced Endothelial Cell Junction Disassembly
Melanoma Cell Migration to Type IV Collagen Requires Activation of NF-kB Chemotaxis is the consequence of environmental factors engaging their receptors to initiate signaling cascades. However, the biochemical mechanisms controlling this phenomenon are not clear. We employed an in vitro modified Boyden 48-well chemotaxis migration system to characterize the role of signal transducers in type IV collagen-induced A2058 human melanoma cell migration. Using specific pharmacological inhibitors and a series of dominant-negative and constitutively active signaling proteins, we show that Ras and Rac GTPases, PI3-K, and PKC participate in cell migration mediated by b1 integrins. Collagen also induces a time-dependent degradation of IkB-a and an increase in nuclear translocation of NF-kB which is dependent on PKC pathway. More importantly, collagen-stimulated melanoma cell migration directly correlated with an increase in NF-kB transactivation. Furthermore, CIV induced an increase in b1 integrin mRNA levels. Specific NF-kB inhibitors Helenalin and SN-50 inhibited melanoma cell migration to collagen, indicating a novel requirement for NF-kB transactivation in cell chemotaxis mediated by b1 integrin signals. These results describe signal transduction events that are initiated by type IV collagen through b1 integrins and demonstrate an important role for NF-kB in regulating melanoma chemotaxis.
This project is in collaboration with Dr. Andrew Henderson in Department of Veterinary Science at Penn State. Return to TopCell Deformation and Adhesion Studies
Previous Studies Lipid Mediated Signaling in Tumor Cell Activation
Cell Motility and Locomotion Studies
|
||
This page is last updated on 12/05/2007